# Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy

> **NCT00202436** · PHASE3 · COMPLETED · sponsor: **Sanquin Research & Blood Bank Divisions** · enrollment: 40 (estimated)

## Conditions studied

- Hemochromatosis

## Interventions

- **PROCEDURE:** Phlebotomy
- **PROCEDURE:** Erythrocytapheresis

## Key facts

- **NCT ID:** NCT00202436
- **Lead sponsor:** Sanquin Research & Blood Bank Divisions
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2008-12
- **Final completion:** 2009-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2009-10-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00202436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00202436, "Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT00202436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*